Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vion's sulfonylhydrazine prodrug enters phase I evaluation

June 27, 2001

EntreMed and Aventis establish collaborative agreement for phase II prostate cancer trial

June 27, 2001

New GH receptor antagonist may have a role in the management of colon cancer

June 26, 2001

Zycos and Aventis Pasteur extend drug discovery alliance

June 26, 2001

Kosan Biosciences awarded SBIR grant for epothilone development

June 25, 2001

IntraDose plus systemic chemotherapy evaluated in H&N cancer patients

June 22, 2001

Recruitment begins in phase II trial of BBR-3464 for pancreatic cancer

June 22, 2001

Irofulven/gemcitabine combination under evaluation in advanced cancers

June 21, 2001

VEGF inhibitors in the AstraZeneca pipeline

June 21, 2001

Cytotoxic topoisomerase inhibitors identified by Rutgers scientists

June 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...